NCT04574960View on ClinicalTrials.gov

Neoadjuvant Upper Tract Invasive Cancer Trial (NAUTICAL)

PHASE3RecruitingINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

February 8, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Bladder CancerBladder Urothelial Carcinoma
Interventions
DRUG

Gemcitabine

Gemcitabine 1000 mg/m\^2, IV infusion on days 1 and 8 of each 3-week cycle

DRUG

Cisplatin

Cisplatin 70 mg/m\^2, IV infusion on day 1 of each 3-week cycle

DRUG

Carboplatin

Carboplatin AUC 5-6 calculated using the Calvert formula on day 1 of each cycle

Trial Locations (2)

K1H8L6

RECRUITING

The Ottawa Hospital, Ottawa

M5G2M9

RECRUITING

University Health Network, Toronto

All Listed Sponsors
collaborator

Bladder Cancer Canada

UNKNOWN

lead

University Health Network, Toronto

OTHER